hyperplasia

(redirected from benign prostatic hyperplasia)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

hyperplasia

(hī'pərplā`zhə): see hypertrophyhypertrophy
, enlargement of a tissue or organ of the body resulting from an increase in the size of its cells. Such growth accompanies an increase in the functioning of the tissue. In normal physiology the growth in size of muscles (e.g.
..... Click the link for more information.
.

Hyperplasia

 

an increase in the number of structural elements of tissues or organs. In man and animals, hyperplasia is based on the intensified reproduction of cells and the formation of new structures. Hyperplasia is observed in various types of pathological growth of tissues (chronic productive inflammation and tumor), in regeneration, and in hypertrophy. Hyperplasia often carries with it compensating characters. In plants, it may be a local growth of tissues resulting from mitotic or amitotic cell division. It occurs with infection by destructive or pathogenic organisms, during trauma, and under the influence of growth stimulants, pesticides, and other preparations. The result of hyperplasia is the formation of galls, calluses, and warts.

hyperplasia

[‚hī·pər′plā·zhə]
(medicine)
Increase in cell number causing an increase in the size of a tissue or organ.
References in periodicals archive ?
Practice patterns of Canadian urologists in benign prostatic hyperplasia and prostate cancer.
Background and Objectives: Urinary Retention (UR) is one of the most serious complication of benign prostatic hyperplasia (BPH), causing resistance in urine flow and hence results in painful urination.
The product is indicated as monotherapy for the treatment of symptomatic benign prostatic hyperplasia in men with an enlarged prostate to improve symptoms, decrease the risk of acute urinary retention and reduce the risk of the need for benign prostatic hyperplasia -related surgery.
These signs should not be ignored or overlooked as they can indicate serious problems, including benign prostatic hyperplasia (BPH), prostatitis, and even prostate cancer.
It also reviews key players involved in the therapeutic development for Benign Prostatic Hyperplasia and special features on late-stage and discontinued projects.
The LUTS associated with benign prostatic hyperplasia (BPH) include both storage/irritative symptoms, such as frequency, urgency, nocturia, and voiding/obstructive symptoms, such as hesitancy and straining to void (Table 1).

Full browser ?